Indefinite Delivery Contract 75D30125D20476
Award Date
7/1/25
Last Date to Order
6/30/26
Federal Agency
CDC Pittsburgh
Awardee
Bavarian Nordic, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Bavarian Nordic, Inc. as a prime contractor. The contract has a ceiling value of $11,475,000.00 and a period of performance from April 1, 2025, through March 30, 2026. The purpose of this IDC is to procure standard commercial pediatric vaccines for the Vaccines for Children (VFC) program. Bavarian Nordic, Inc., as a vaccine manufacturer, will be required to provide vaccines with a...
The federal contract IDV award is for the purchase of various pediatric vaccines by the Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases (NCIRD). The multiple-award, indefinite delivery, indefinite quantity (IDIQ) contract has a total ceiling value of $28,687,500 and a period of performance from April 1, 2024 to March 31, 2025. The solicitation seeks to procure between 100 doses and 13 million doses of 27 different pediatric vaccines,...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) awarded an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Bavarian Nordic, Inc. for the procurement of various adult vaccines. The $99,015,000 multiple-award contract has a period of performance from July 1, 2024 to June 30, 2025. The contract does not utilize any set-asides. The solicitation seeks the purchase of vaccines for Hepatitis A, Hepatitis B, Hepatitis...
This federal Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, for the procurement of adult vaccines. The IDC has a total ceiling value of $105,362,800 and a period of performance through June 30, 2026. The contract is a multiple award vehicle that does not have any set-aside designations. It supports critical national immunization efforts by allowing the CDC and...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Dynavax Technologies Corporation, a biopharmaceutical company focused on immune system responses. The contract, valued at $28,105,875.00, covers the provision of adult vaccines to support the CDC's national immunization programs. As a multiple-award IDC, the contract allows for the continued issuance of task orders to Dynavax over the performance period, which runs through June 30,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Dynavax Technologies Corporation, a biopharmaceutical company focused on immune system responses for disease prevention and treatment. The $58.455 million multiple-award IDC has a period of performance through June 30, 2026 and is for the procurement of adult vaccines to support the CDC's national immunization programs. Dynavax, which has experience conducting clinical trials and...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Bavarian Nordic, Inc., is for the procurement of drugs, pharmaceuticals, and hematology-related products over a 5-year period with a $10 million ceiling value. Bavarian Nordic, a biotechnology company focused on developing cancer immunotherapies and vaccines, holds multiple Federal Supply Schedule contracts that allow federal agencies to efficiently procure pharmaceuticals, drugs, and vaccines as needed....
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, valued at a ceiling of $66,688,290, is for the procurement of adult vaccines under the VACCINES major program code. The contract has a period of performance from July 1, 2025 to June 30, 2026. As an established federal contractor, Merck holds several significant IDVs with the CDC,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. for the purchase of various adult vaccines. The $118.2 million contract, running from July 1, 2024 to June 30, 2025, covers a diverse array of vaccines including Hepatitis, HPV, Measles/Mumps/Rubella, Meningococcal, Mpox, Pneumococcal, and Varicella. The contract does not utilize any set-asides and allows for...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, to supply a variety of adult vaccines over a one-year period from July 1, 2023 through June 30, 2024. The total contract ceiling value is $232,487,206.61. The contract covers the procurement of an estimated 1.5 to 3 million doses of 12 different adult vaccines, including hepatitis A, hepatitis B, hepatitis A &...